Bitte benutzen Sie diese Referenz, um auf diese Ressource zu verweisen: doi:10.22028/D291-44213
Volltext verfügbar? / Dokumentlieferung
Titel: Development of an In-vitro Drug Delivery Efficiency Test for a Pulmonary Toxicokinetic Pig Study
VerfasserIn: Schaefer, Nadine
Kroll, Ann K.
Laschke, Matthias W.
Menger, Michael D.
Maurer, Hans H.
Meyer, Markus R.
Schmidt, Peter H.
Sprache: Englisch
Titel: Current Drug Delivery
Bandnummer: 15
Heft: 8
Seiten: 1167-1171
Verlag/Plattform: Bentham Science Publications
Erscheinungsjahr: 2018
Freie Schlagwörter: Synthetic cannabinoids
tetrahydrocannabinol
drug delivery efficiency
nebulization
toxicokinetics
LC-MS/MS
DDC-Sachgruppe: 610 Medizin, Gesundheit
Dokumenttyp: Journalartikel / Zeitschriftenartikel
Abstract: Background: Since their appearance on the drugs of abuse market, synthetic cannabinoids (SCs) are gaining increasing toxicological relevance. They are consumed without knowledge of their toxicokinetic (TK) and toxicodynamic properties and human studies are not allowed due to ethical reasons. A controlled animal TK study following nebulization of 4-ethylnaphthalene-1-yl-(1-pentylindole- 3-yl)methanone (JWH-210), 2-(4-methoxyphenyl)-1-(1-pentyl-indole-3-yl)methanone (RCS-4) as well as Δ9-tetrahydrocannabinol (THC) to pigs should be helpful for better interpretation of analytical results in cases of misuse or poisoning. As a prerequisite, an in-vitro test system mimicking a ventilated pig had to be developed to determine the quantity and reproducibility of which drug dose is delivered to the pig lung. Methods: JWH-210, RCS-4, and THC (1 mg in 2 mL ethanol each) were nebulized during ventilation using an ultrasonic nebulizer. The drug aerosol was delivered via the inspiratory limb and the endotracheal tube passing through a glass fiber filter (n = 6). The drugs were extracted from the filters using ethanol and ultrasonication. After several dilution steps and adding an internal standard solution, the extracts were analyzed by LC-MS/MS. Results: Extraction of the nebulized drugs revealed delivery efficiencies of 78.8 ± 5.0% for JWH-210, 70.5 ± 6.9% for RCS-4, and 70.8 ± 7.9% for THC. The loss of about 20-30% of the administered dose might be attributable to retention in the nebulizer device or adhesion of the aerosol particles to the tube wall. Conclusion: Nevertheless, regarding delivery efficiencies, the minor standard deviations indicate an acceptable reproducibility, suggesting that this administration system is suitable for application in TK studies.
DOI der Erstveröffentlichung: 10.2174/1567201815666180214130014
URL der Erstveröffentlichung: http://dx.doi.org/10.2174/1567201815666180214130014
Link zu diesem Datensatz: urn:nbn:de:bsz:291--ds-442133
hdl:20.500.11880/39521
http://dx.doi.org/10.22028/D291-44213
ISSN: 1567-2018
Datum des Eintrags: 29-Jan-2025
Fakultät: M - Medizinische Fakultät
Fachrichtung: M - Chirurgie
M - Experimentelle und Klinische Pharmakologie und Toxikologie
M - Rechtsmedizin
Professur: M - Prof. Dr. Michael D. Menger
M - Prof. Dr. Markus Meyer
M - Prof. Dr. Peter Schmidt
Sammlung:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Dateien zu diesem Datensatz:
Es gibt keine Dateien zu dieser Ressource.


Alle Ressourcen in diesem Repository sind urheberrechtlich geschützt.